Clopid As Tablet

Clopid As Tablet


Clopidogrel selectively inhibits the binding of ADP (Adenosine Diphosphate) to its platelet receptor and the subsequent ADP mediated activation of glycoprotein GP IIb / IIIa complex, thereby inhibiting platelet aggregation. Clopidogrel has received a USFDA approval in patients with acute STEMI (ST Segment Elevated Myocardial Infarction)


Clopid AS Tablet is used in the treatment of acute coronary syndrome which is a condition that blocks the blood flow to the heart muscles.

* To be consumed as directed by physician.

Product Enquiry